Explore All Access
Check if your research matches the topics covered in Targeted Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Targeted Oncology : Impact Factor & More
eISSN: 1776-260XpISSN: 1776-2596
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Targeted Oncology Key Metrics
CiteScore 
7.2
Impact Factor
5 - 10
SJR
Q2Oncology
SNIP
1.03
Topics Covered on Targeted Oncology
Epidermal growth factor receptor
Lung cancer
P53 expression
Progression-free survival
Breast cancer
Hepatocellular carcinoma
Crizotinib
Copanlisib
Overall survival
Pembrolizumab
Confidence interval
Adenocarcinoma
Objective response
Colorectal cancer
Mutation testing
Cerebrospinal fluid
Immunotherapy
Metastatic breast cancer
Melanoma
Erlotinib
Targeted Oncology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Targeted Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Targeted Oncology
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma.
- 15 Nov 2024
- Targeted oncology
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis.
- 13 Nov 2024
- Targeted oncology
Post-Metastasis Survival of Patients with High-Risk Localized and Locally Advanced Prostate Cancer Undergoing Primary Treatment in the United States: A Retrospective Study.
- 10 Nov 2024
- Targeted oncology
Delayed Separation of Kaplan-Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis.
- 10 Nov 2024
- Targeted oncology
Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study.
- 7 Nov 2024
- Targeted oncology
Acknowledgement to Referees.
- 6 Nov 2024
- Targeted oncology
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma.
- 15 Nov 2024
- Targeted oncology
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis.
- 13 Nov 2024
- Targeted oncology
Post-Metastasis Survival of Patients with High-Risk Localized and Locally Advanced Prostate Cancer Undergoing Primary Treatment in the United States: A Retrospective Study.
- 10 Nov 2024
- Targeted oncology
Delayed Separation of Kaplan-Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis.
- 10 Nov 2024
- Targeted oncology
Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study.
- 7 Nov 2024
- Targeted oncology
Acknowledgement to Referees.
- 6 Nov 2024
- Targeted oncology
Compare Similar Journals with Targeted Oncology
Select Journals to Compare with Targeted Oncology
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
BMC Cancer
Publisher: BMC
Oncotarget
Publisher: Impact Journals
0 Journals Selected to compare with
Targeted Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Targeted Oncology
How long has Targeted Oncology been actively publishing? 
Targeted Oncology has been in operation since 2006 till date.
What is the publishing frequency of Targeted Oncology?
Targeted Oncology published with a Bi-monthly frequency.
How many articles did Targeted Oncology publish last year?
In 2023, Targeted Oncology publsihed 82 articles.
What is the eISSN & pISSN for Targeted Oncology?
For Targeted Oncology, eISSN is 1776-260X and pISSN is 1776-2596.
What is Citescore for Targeted Oncology?
Citescore for Targeted Oncology is 7.2.
What is SNIP score for Targeted Oncology?
SNIP score for Targeted Oncology is 1.03.
What is the SJR for Targeted Oncology?
SJR for Targeted Oncology is Q2.
Who is the publisher of Targeted Oncology?
SPRINGER is the publisher of Targeted Oncology.
